Erratum: Disruption of MycMax Heterodimerization with Improved CellPenetrating Analogs of the Small Molecule 10074G5

Huabo Wang¹, Jay Chauhan², Angela Hu¹, Kelsey Pendleton¹, Jeremy L. Yap², Philip E. Sabato³, Jace W. Jones², Mariarita Perri⁴, Jianshi Yu², Erika Cione⁴, Maureen A. Kane^2,5, Steven Fletcher^2,5 and Edward V. Prochownik^1,6,7

¹ Section of Hematology/Oncology, Children’s Hospital of Pittsburgh of UPMC
² Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, MD, USA
³ PharmD Program, University of Maryland School of Pharmacy, Baltimore, MD, USA
⁴ Department of Pharmaco-Biology, University of Calabria, Rende (CS), Italy
⁵ University of Maryland Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD, USA
⁶ Department of Microbiology and Molecular Genetics, The University of Pittsburgh School of Medicine
⁷ The University of Pittsburgh Cancer Institute, Pittsburgh, PA

Published: October 12, 2018

This article has been corrected: During production, the ending page number for this article was listed incorrectly. The page count has now been adjusted to show the proper pagination.

Original article: Oncotarget. 2013; 4:936-947. DOI: https://doi.org/10.18632/oncotarget.1108.